Food and Drug Administration

FDA Alerts Public to Philips Respironics Ventilator Correction Over In-Line Nebulizer Concerns

WASHINGTON, D.C. — The United States Food and Drug Administration has issued a crucial announcement concerning a voluntary correction by Philips Respironics regarding their Trilogy Evo series ventilators. This correction addresses …

FDA Alerts Public to Philips Respironics Ventilator Correction Over In-Line Nebulizer Concerns Read More


Philips’ DreamStation 2 CPAP Machines

FDA Issues Safety Alert on Philips Respironics’ DreamStation 2 CPAP Machines Due to Overheating Risks

The U.S. Food and Drug Administration (FDA) has recently issued an alert for patients and healthcare providers regarding a safety issue involving the DreamStation 2 Continuous Positive Airway Pressure (CPAP) …

FDA Issues Safety Alert on Philips Respironics’ DreamStation 2 CPAP Machines Due to Overheating Risks Read More